go back

Perphenazine, Oral

Rhode Island rates for HCPCS Q0175

Perphenazine, 4 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at the time of chemotherapy treatment, not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $1 · 10th–90th $0$20%50%10th90th$1Professionalmedian $0 · 10th–90th $0$00%50%10th$0$0.5$1.0$2.0$5.0$10.0$20.0$50.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$0.91
Median
$1.82
Typical High
$1.82
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.45
Median
$0.48
Typical High
$0.48
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.50
Median
$0.50
Typical High
$0.52
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.50
Median
$0.50
Typical High
$0.50
Cigna
Setting
Facility
Modifier
Global
Typical Low
$0.48
Median
$0.48
Typical High
$0.91
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.48
Median
$0.48
Typical High
$0.48
United
Setting
Professional
Modifier
Global
Typical Low
$0.47
Median
$0.47
Typical High
$2.04